-
According to a new survey of clinicians who treat teen girls with pelvic inflammatory disease (PID), national guidance designed to inform decisions about hospitalization versus outpatient care has lead to provider uncertainty in choosing the most effective treatment approach.
-
Women with breast cancer susceptibility gene (BRCA) mutations are at risk for breast and ovarian cancers. Ovarian cancer often escapes early detection because laboratory and imaging screening tools are less effective than those developed for breast cancer. Ovarian cancer is marked with a less-robust five-year survival rate (44%), compared with nearly 90% for breast cancer.
-
The contraceptive vaginal ring (NuvaRing, Merck & Co., Whitehouse Station, NJ) and patch (Ortho Evra, Ortho Womens Health & Urology, Raritan, NJ). are two effective options for women who choose combined hormonal methods.
-
When it comes to family planning, more women are choosing long-acting reversible contraception (LARC) methods such as intrauterine devices (IUDs) and the contraceptive implant, say respondents to the 2012 Contraceptive Technology Update Contraception Survey.
-
The upswing of use of long-acting reversible contraception is making an impact on the use of combined oral contraceptives (oCs), according to responses to the 2012 Contraceptive Technology Update Contraception Survey.
-
Birth control sabotage in which a partner deliberately pokes holes in condoms, destroys birth control pills, or tampers with the efficacy of a method is not uncommon.
-
While several protocols are available to start women on a combined oral contraceptive (OC), respondents to the 2012 Contraceptive Technology Update Contraception Survey are firmly behind the Quick Start method of pill initiation.
-
-
-
